3D printed medical devices market seen reaching $8.83 billion by 2030

The Business Research Company projects the 3D printed medical devices market will grow from $4.1 billion in 2025 to $4.83 billion in 2026, then nearly double to $8.83 billion by 2030. Cardiovascular demand, point-of-care manufacturing and clearer regulation are expected to drive the next phase of growth.

Why it matters: - 3D printed medical devices are moving from niche innovation to a larger part of healthcare manufacturing. - The market is forecast to grow fast as hospitals and manufacturers look for personalized implants, surgical tools and patient-specific models. - Cardiovascular care is a major demand driver because clinicians use 3D printed models to support planning and treatment.

What happened: - The Business Research Company released a report on the global 3D printed medical devices market covering market size, trends and a 2026-2035 forecast. - The market is estimated at $4.1 billion in 2025 and projected to rise to $4.83 billion in 2026. - The report projects the market will reach $8.83 billion by 2030. - North America held the largest market share in 2025, with Western Europe in second place. - The report also covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa. - A free sample is available here. - The full report is available here.

The details: - 3D printed medical devices are artificial implants or replacements for missing body parts or biological structures. - The devices are created by layering materials from detailed digital 3D models. - The approach allows highly precise, customizable products for individual patient needs. - Early market growth has been driven by demand for tailored medical solutions, adoption of 3D printed surgical instruments, integration with medical imaging, higher research activity and certified printing technologies. - The report expects growth to accelerate through 2030 at a 16.3% CAGR. - Supporting factors include point-of-care manufacturing, clearer regulatory frameworks, more investment in digital healthcare systems, faster device development cycles and advances in bioprinting and tissue engineering. - Key trends include custom device fabrication, multi-material printing, software-driven design tools, on-demand production, rapid prototyping and validation. - The report says the 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables.

Between the lines: - The market’s growth story is shifting from proof of concept to operational scale. - Clearer regulation and point-of-care manufacturing could make 3D printing easier to adopt in clinical settings. - Cardiovascular disease gives the category a concrete use case with measurable patient demand. - The British Heart Foundation reported in September 2025 that more than 7.6 million people in the UK were living with cardiovascular disease. - That total included more than 4 million men and 3.6 million women. - The British Heart Foundation projected the number could rise by about 1 million by 2030 and around 2 million by 2040 because of an aging population and better survival rates.

What's next: - The market is expected to keep expanding as bioprinting and tissue engineering mature. - Adoption may increase as digital healthcare investment and device validation processes advance. - North America is likely to remain a key regional hub if current innovation and adoption patterns continue.

The bottom line: - 3D printed medical devices are becoming a faster-growing healthcare category, with demand strongest where customization and clinical precision matter most.